Results 111 to 120 of about 230,556 (169)

Evaluation of contrast sensitivity function and optic nerve head in patients diagnosed with graves without orbitopathy

Amaç: Graves hastalarında fonksiyonel göz hasarı gelişmeden önce, subklinik evrede gerçekleştirilecek erken tanı ve uygun takip yöntemleriyle geri dönüşü olmayan görme kaybının önlenmesi amaçlanmıştır. Materyal ve Metod: 30 Graves orbitopatisi olan hasta,
Azız, Marıam
core  

Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]

Eur Thyroid J
Lee ACH, Kahaly GJ.
europepmc   +1 more source

Dysthyroid Optic Neuropathy in Graves' Orbitopathy: Insights from a Single Centre and Limitations of the Radiological Indices. [PDF]

Indian J Endocrinol Metab
Agarwal K, Joy AA, Veerappan M, Rallapalli SS, Peter J, Sahu S, Kandagaddala M, Asha HS, Kapoor N, Cherian KE, Rebekah G, Jebasingh FK, Thomas N.   +12 more
europepmc   +1 more source

Efficacy and safety of secondary infero-medial orbital wall decompression after orbital fat decompression in Graves' orbitopathy: A 12-year experience. [PDF]

Indian J Ophthalmol
Cheng AMS, Fu YT, Wei YH, Chuang AY, Bair H, Yang ES, Liao SL.   +6 more
europepmc   +1 more source

Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]

Sci Rep
Pérez-Moreiras J, Abelenda D, Providência J, Castela G.   +3 more
europepmc   +1 more source

Correction: Role of the suppressor of cytokine signaling-3 in the pathogenesis of Graves' orbitopathy. [PDF]

Front Endocrinol (Lausanne)
Kim W, Seo MK, Kim YJ, Choi SH, Ku CR, Kim S, Lee EJ, Yoon JS.   +7 more
europepmc   +1 more source

The impact of graves' orbitopathy on anterior segment structures and choroidal parameters. [PDF]

BMC Ophthalmol
Sevimli N, Eryılmaz M, Azarbaz MK, Taydaş G.   +3 more
europepmc   +1 more source

Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impact. [PDF]

Microbiome
Wang D, Chen Y, Yang J, Zhang Y, Deng X, Liu Y, Chen Y, Yang X, Wang X, Liang C, Xie Q, Hao Y, Yuan H.   +12 more
europepmc   +1 more source

Extracellular vesicles in Graves' disease and Graves' orbitopathy: immunoregulatory mechanisms, biomarkers, and therapeutic potentials. [PDF]

Front Immunol
Chen Y, Yang Y, Yang S, Yuan W, Jiang L, Wei R.   +5 more
europepmc   +1 more source

Therapeutic targets for fibro-inflammation in Graves' orbitopathy. [PDF]

Taiwan J Ophthalmol
Kang YJ, Yoon JS.
europepmc   +1 more source